Notably, pDCs are the major producers of IFN-α in SLE, and IFN-α production from pDC mediated by TLR9 is reduced by mTOR inhibitor, which regulates pDC differentiation and activation by modulating mitochondrial biogenesis and energy metabolism (78). Here, MTOR is linked to systemic lupus erythematosus.